Arsenic based traditional herbometallic nanodrug targeting energy metabolism in metastatic breast cancer: a therapeutic approach

---

Authors

Bhuban Ruidas¹ , Pritha Das² , Chitrangada Das Mukhopadhyay³

1. Senior Research Scholar
2. Professor
3. Assistant Professor

Conference / event

Translational Cancer Research Conference (TCR-2020), February 2020 (Varanasi, India)

Poster summary

The progression of metastatic triple negative breast cancer (TNBC) is critically relient on comepensating for the excessive energy needs of cancer cells through metabolic fueling. Therefore, targeting cell metabolism of TNBC could be a promising therapeutic approach. in this study, we introduce a naturally synthesized herbometallic nanodrug containing arsenic that actively interferes with TNBC metabolism and exhibits promising anticancer activities.

Keywords

Metastatic TNBC, Herbometallic, Metabolism, Anticancer, Mito and glyco stress, Apoptosis

Research areas

Biological Sciences, Medicine, Biochemistry, Molecular and Cellular Biosciences, Pharmacy and Pharmacology

References

No data provided

Funding

No data provided

Supplemental files

No data provided

Additional information

Competing interests

No competing interests were disclosed.

Data availability statement

The datasets generated during and / or analyzed during the current study are available from the corresponding author on reasonable request.

Creative Commons license

Copyright © 2023 Ruidas et al. This is an open access work distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.